Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Shigella flexneri cell-to-cell spread, and growth and inflammation in mice, is limited by the outer membrane protease IcsP.

Tran EN, Attridge SR, Teh MY, Morona R.

FEMS Microbiol Lett. 2015 Jun;362(12):fnv088. doi: 10.1093/femsle/fnv088. Epub 2015 May 29.

PMID:
26025071
2.

Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infection.

Lum M, Attridge SR, Morona R.

PLoS One. 2013 Dec 19;8(12):e84975. doi: 10.1371/journal.pone.0084975. eCollection 2013.

4.

Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae.

Nygren E, Li BL, Holmgren J, Attridge SR.

Infect Immun. 2009 Aug;77(8):3475-84. doi: 10.1128/IAI.01197-08. Epub 2009 May 26.

5.

Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide.

Attridge SR, Wallerström G, Li BL, Morona R, Holmgren J.

Vaccine. 2009 Feb 11;27(7):1055-61. doi: 10.1016/j.vaccine.2008.11.101. Epub 2008 Dec 17.

PMID:
19100303
6.

Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.

Nygren E, Holmgren J, Attridge SR.

Vaccine. 2008 Dec 9;26(52):6784-90. doi: 10.1016/j.vaccine.2008.10.011. Epub 2008 Oct 23.

PMID:
18951939
8.

Inducible serum resistance in Salmonella typhimurium is dependent on wzz(fepE)-regulated very long O antigen chains.

Murray GL, Attridge SR, Morona R.

Microbes Infect. 2005 Oct;7(13):1296-304. Epub 2005 Jun 9.

PMID:
16027021
9.
10.

Detection of antibodies to toxin-coregulated pili in sera from cholera patients.

Attridge SR, Wallerström G, Qadri F, Svennerholm AM.

Infect Immun. 2004 Mar;72(3):1824-7.

11.

Vector priming reduces the immunogenicity of Salmonella-based vaccines in Nramp1+/+ mice.

Vindurampulle CJ, Attridge SR.

Infect Immun. 2003 Apr;71(4):2258-61.

13.

Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.

Vindurampulle CJ, Attridge SR.

Infect Immun. 2003 Jan;71(1):287-97.

14.

Cloning and characterization of a novel haemolysin in Vibrio cholerae O1 that does not directly contribute to the virulence of the organism.

Fallarino A, Attridge SR, Manning PA, Focareta T.

Microbiology. 2002 Jul;148(Pt 7):2181-9.

PMID:
12101305
15.

Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.

Attridge SR, Johansson C, Trach DD, Qadri F, Svennerholm AM.

Clin Diagn Lab Immunol. 2002 Mar;9(2):383-7.

16.

Isolation and characterization of bacteriophage-resistant mutants of Vibrio cholerae O139.

Attridge SR, Fazeli A, Manning PA, Stroeher UH.

Microb Pathog. 2001 Apr;30(4):237-46.

PMID:
11312617
17.

Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili.

Eko FO, Mayr UB, Attridge SR, Lubitz W.

J Biotechnol. 2000 Sep 29;83(1-2):115-23.

PMID:
11000467
18.

Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis.

Attridge SR, Qadri F, Albert MJ, Manning PA.

Clin Diagn Lab Immunol. 2000 May;7(3):444-50.

19.

Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.

Attridge SR, Voss E, Manning PA.

J Biotechnol. 1999 Aug 20;73(2-3):109-17. Review.

PMID:
10486921
20.

Characterization of the Vibrio cholerae El Tor lipase operon lipAB and a protease gene downstream of the hly region.

Ogierman MA, Fallarino A, Riess T, Williams SG, Attridge SR, Manning PA.

J Bacteriol. 1997 Nov;179(22):7072-80.

21.
22.
23.

Comparison of the promoter proximal regions of the toxin-co-regulated tcp gene cluster in classical and El Tor strains of Vibrio cholerae O1.

Ogierman MA, Voss E, Meaney C, Faast R, Attridge SR, Manning PA.

Gene. 1996 Apr 17;170(1):9-16.

PMID:
8621096
24.

The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor.

Voss E, Manning PA, Attridge SR.

Microb Pathog. 1996 Mar;20(3):141-53.

PMID:
8965675
25.

Vibrio cholerae Hcp, a secreted protein coregulated with HlyA.

Williams SG, Varcoe LT, Attridge SR, Manning PA.

Infect Immun. 1996 Jan;64(1):283-9.

26.

Thymine auxotrophy as an attenuating marker in Vibrio cholerae.

Attridge SR.

Microb Pathog. 1995 Jul;19(1):11-8.

PMID:
8559036
27.

Immunogenicity of the Escherichia coli fimbrial antigen K99 when expressed by Salmonella enteritidis 11RX.

Bertram EM, Attridge SR, Kotlarski I.

Vaccine. 1994 Nov;12(15):1372-8.

PMID:
7887013
28.

Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs.

Morona R, Morona JK, Considine A, Hackett JA, van den Bosch L, Beyer L, Attridge SR.

Vaccine. 1994 May;12(6):513-7.

PMID:
7913567
29.

The role of toxin-coregulated pili in the pathogenesis of Vibrio cholerae O1 El Tor.

Attridge SR, Voss E, Manning PA.

Microb Pathog. 1993 Dec;15(6):421-31.

PMID:
7911968
30.

In vitro production of toxin-coregulated pili by Vibrio cholerae El Tor.

Voss E, Attridge SR.

Microb Pathog. 1993 Oct;15(4):255-68.

PMID:
7906005
31.

The transcriptional activator HlyU of Vibrio cholerae: nucleotide sequence and role in virulence gene expression.

Williams SG, Attridge SR, Manning PA.

Mol Microbiol. 1993 Aug;9(4):751-60.

PMID:
8231807
32.

Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen.

Attridge SR, Dearlove C, Beyer L, van den Bosch L, Howles A, Hackett J, Morona R, LaBrooy J, Rowley D.

Infect Immun. 1991 Jul;59(7):2279-84.

33.

Role of the P plasmid in attenuation of Vibrio cholerae O1.

Bartowsky EJ, Attridge SR, Thomas CJ, Mayrhofer G, Manning PA.

Infect Immun. 1990 Sep;58(9):3129-34.

34.

Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Tacket CO, Forrest B, Morona R, Attridge SR, LaBrooy J, Tall BD, Reymann M, Rowley D, Levine MM.

Infect Immun. 1990 Jun;58(6):1620-7.

35.

Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210.

Attridge SR, Daniels D, Morona JK, Morona R.

Microb Pathog. 1990 Mar;8(3):177-88.

PMID:
1696342
37.

Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.

Sharma DP, Thomas C, Hall RH, Levine MM, Attridge SR.

Vaccine. 1989 Oct;7(5):451-6.

PMID:
2573216
38.

The in vitro proliferative response of lymphoid cells of mice infected with Salmonella enteritidis 11RX.

Kotlarski I, Pope M, Doherty K, Attridge SR.

Immunol Cell Biol. 1989 Feb;67 ( Pt 1):19-29.

PMID:
2656506
39.

Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans.

Forrest BD, LaBrooy JT, Attridge SR, Boehm G, Beyer L, Morona R, Shearman DJ, Rowley D.

J Infect Dis. 1989 Jan;159(1):145-6. No abstract available.

PMID:
2909633
40.

A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.

Hone DM, Attridge SR, Forrest B, Morona R, Daniels D, LaBrooy JT, Bartholomeusz RC, Shearman DJ, Hackett J.

Infect Immun. 1988 May;56(5):1326-33.

41.
42.

The effect of limited courses of cyclosporine on survival and immunocompetence of allogeneic bone marrow chimeras.

Denham S, Attridge SR, Barfoot RK.

Transplantation. 1985 Nov;40(5):477-82.

PMID:
2932820
43.

In vitro lymphokine release by lymphocytes from mice infected with Salmonella.

Attridge SR, Kotlarski I.

Aust J Exp Biol Med Sci. 1985 Oct;63 ( Pt 5):489-502.

PMID:
3911930
44.

The effects of Amicon and millipore membranes upon the lymphokine titres of culture supernatants.

Attridge SR, Kotlarski I.

Aust J Exp Biol Med Sci. 1984 Oct;62 ( Pt 5):547-50.

PMID:
6335964
45.

Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.

Attridge SR, Rowley D.

J Infect Dis. 1983 Nov;148(5):931-9.

PMID:
6195273
47.

The role of the flagellum in the adherence of Vibrio cholerae.

Attridge SR, Rowley D.

J Infect Dis. 1983 May;147(5):864-72.

PMID:
6842021

Supplemental Content

Loading ...
Support Center